René Russo

2017 - X4 Pharmaceuticals

In 2017, René Russo earned a total compensation of $1.2M as President and Chief Executive Officer at X4 Pharmaceuticals, a 48% increase compared to previous year.

Compensation breakdown

Bonus$254,100
Option Awards$524,182
Salary$388,750
Total$1,167,032

Russo received $524.2K in option awards, accounting for 45% of the total pay in 2017.

Russo also received $254.1K in bonus and $388.8K in salary.

Rankings

In 2017, René Russo's compensation ranked 8,231st out of 14,666 executives tracked by ExecPay. In other words, Russo earned more than 43.9% of executives.

ClassificationRankingPercentile
All
8,231
out of 14,666
44th
Division
Manufacturing
3,112
out of 5,772
46th
Major group
Chemicals And Allied Products
1,024
out of 2,075
51st
Industry group
Drugs
806
out of 1,731
53rd
Industry
Biological Products, Except Diagnostic Substances
148
out of 313
53rd
Source: SEC filing on April 23, 2018.

Russo's colleagues

We found six more compensation records of executives who worked with René Russo at X4 Pharmaceuticals in 2017.

2017

René BCPS

X4 Pharmaceuticals

Chief Executive Officer

2017

Michael Gray

X4 Pharmaceuticals

Chief Financial Officer

2017

Paula Ragan

X4 Pharmaceuticals

Chief Executive Officer

2017

Christopher Stevens

X4 Pharmaceuticals

Chief Medical Officer

2017

Chris Stevens

X4 Pharmaceuticals

Chief Medical Officer

2017

David Mantus

X4 Pharmaceuticals

Former Chief Development Officer

News

You may also like